252 related articles for article (PubMed ID: 5252042)
21. A review of the preclinical antitumor activity and toxicology of L-asparaginase derived from E. coli.
Charles LM; Bono VH
Cancer Treat Rep; 1981; 65 Suppl 4():39-46. PubMed ID: 7049380
[No Abstract] [Full Text] [Related]
22. [The best chemotherapy in the world can only give what it can].
Mathé G
Nouv Presse Med; 1972 Jun; 1(26):1753-6. PubMed ID: 4115468
[No Abstract] [Full Text] [Related]
23. Comparison of antitumor effect of recombinant L-asparaginase with wild type one in vitro and in vivo.
Guo QL; Wu MS; Chen Z
Acta Pharmacol Sin; 2002 Oct; 23(10):946-51. PubMed ID: 12370101
[TBL] [Abstract][Full Text] [Related]
24. L-asparaginase and immune reactions.
Astaldi G
Przegl Lek; 1972; 29(6):595-7. PubMed ID: 4507012
[No Abstract] [Full Text] [Related]
25. In-vitro cytotoxicity of L-asparaginase on rodent and human neoplastic cells.
Schrek R; Dolowy WC
Lancet; 1970 Oct; 2(7675):722. PubMed ID: 4195957
[No Abstract] [Full Text] [Related]
26. [Inhibition of lymphocyte transformation by L-asparaginase in acute leukemia].
Giraudo Conesa LC; Pavlovsky S; Scornik JC
Medicina (B Aires); 1971; 31(5):434-9. PubMed ID: 5293416
[No Abstract] [Full Text] [Related]
27. Clinical evaluation of succinylated Acinetobacter glutaminase-asparaginase in adult leukemia.
Warrell RP; Arlin ZA; Gee TS; Chou TC; Roberts J; Young CW
Cancer Treat Rep; 1982 Jul; 66(7):1479-85. PubMed ID: 7046929
[TBL] [Abstract][Full Text] [Related]
28. Correlation between the cytostatic, immunosuppressive and tryptophane pyrrolase induction inhibiting effect of L-asparaginase.
Hernádi F; Daróczy A; Szeverényi M
Acta Biol Acad Sci Hung; 1974; 25(3):199-203. PubMed ID: 4466284
[No Abstract] [Full Text] [Related]
29. Therapy of acute leukemia.
Holland JF
Hamatol Bluttransfus; 1970; 9():58-65. PubMed ID: 5279393
[No Abstract] [Full Text] [Related]
30. L-asparaginase therapy for leukemia and other malignant neoplasms. Remission in human leukemia.
Hill JM; Roberts J; Loeb E; Khan A; MacLellan A; Hill RW
JAMA; 1967 Nov; 202(9):882-8. PubMed ID: 5234350
[No Abstract] [Full Text] [Related]
31. An outline of cancer chemotherapy.
Connors TA
Rev Roum Inframicrobiol; 1971; 8(3):135-51. PubMed ID: 5152643
[No Abstract] [Full Text] [Related]
32. [Progress in researches on anti-tumor agent L-asparaginase for treatment of leukemia].
Zhou J; Jin H; Li Y; Jiang T
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2000 Sep; 17(3):343-5. PubMed ID: 11285852
[TBL] [Abstract][Full Text] [Related]
33. Biochemical and pharmacological studies with asparaginase in man.
Ohnuma T; Holland JF; Freeman A; Sinks LF
Cancer Res; 1970 Sep; 30(9):2297-305. PubMed ID: 4920133
[No Abstract] [Full Text] [Related]
34. Dantrolene and potentially fatal hyperthermia secondary to L-asparaginase.
Smithson WA; Gronert GA; Moss KK
Cancer Treat Rep; 1983 Mar; 67(3):318-9. PubMed ID: 6572565
[No Abstract] [Full Text] [Related]
35. In vitro test for sensitivity of leukemic cells to L-asparaginase.
Schrek R; Dolowy WC
Cancer Res; 1971 May; 31(5):523-6. PubMed ID: 4932205
[No Abstract] [Full Text] [Related]
36. Antileukemic effect of L-aspartyl-hydrazine.
Stern P; Valjevac K; Balenović K
Neoplasma; 1975; 22(1):69-71. PubMed ID: 1153038
[TBL] [Abstract][Full Text] [Related]
37. Influence of a benign virus upon mouse leukemia during asparaginase therapy.
Riley V
Pathol Biol (Paris); 1970; 18(15):757-64. PubMed ID: 4917552
[No Abstract] [Full Text] [Related]
38. [L-asparaginase in the treatment of the acute leukemias. Biological aspects].
Astaldi G
Sangre (Barc); 1971; 16(1):1-6. PubMed ID: 5280755
[No Abstract] [Full Text] [Related]
39. [Treatment of acute leukemia in adults].
Stavem P; Gjemdal T
Tidsskr Nor Laegeforen; 1971 Nov; 91(33):2410-8. PubMed ID: 5289258
[No Abstract] [Full Text] [Related]
40. L-asparaginase treatment of acute myeloblastic leukemia.
Hansen HH; Canellos GP
Oncology; 1970; 24(5):349-57. PubMed ID: 5275037
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
